| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.19T | 28.25T | 26.38T | 26.29T | 25.64T | 24.90T |
| Gross Profit | 17.92T | 18.10T | 17.02T | 16.72T | 15.90T | 14.86T |
| EBITDA | 6.40T | 6.70T | 4.88T | 5.53T | 5.90T | 5.89T |
| Net Income | 1.53T | 1.72T | 459.86B | 993.33B | 1.26T | 1.36T |
Balance Sheet | ||||||
| Total Assets | 42.87T | 42.95T | 42.01T | 42.78T | 40.64T | 37.14T |
| Cash, Cash Equivalents and Short-Term Investments | 4.64T | 5.02T | 4.89T | 4.27T | 3.70T | 4.17T |
| Total Debt | 12.05T | 12.21T | 11.62T | 11.39T | 11.08T | 9.59T |
| Total Liabilities | 23.17T | 23.49T | 23.96T | 24.24T | 22.38T | 20.58T |
| Stockholders Equity | 17.92T | 17.65T | 16.26T | 16.72T | 16.47T | 14.97T |
Cash Flow | ||||||
| Free Cash Flow | 2.13T | 1.36T | 2.16T | 1.33T | -390.07B | 1.31T |
| Operating Cash Flow | 4.94T | 5.01T | 5.07T | 5.50T | 3.60T | 5.56T |
| Investing Cash Flow | -3.96T | -4.56T | -2.85T | -4.62T | -4.84T | -5.14T |
| Financing Cash Flow | -1.28T | -655.68B | -1.39T | -452.79B | 669.33B | -41.28B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $5.93B | 22.78 | 5.46% | 0.40% | 61.86% | -115.00% | |
70 Outperform | $10.16B | 12.13 | 17.55% | 7.82% | 8.21% | 30.97% | |
66 Neutral | $8.38B | 9.72 | 8.77% | 4.13% | 13.45% | 148.36% | |
64 Neutral | $15.08B | 17.05 | 12.76% | 6.14% | -4.78% | -32.55% | |
62 Neutral | $14.46B | 60.70 | 3.00% | 5.02% | -7.08% | -73.85% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | $4.98B | 12.42 | 7.27% | 5.57% | 18.57% | 5.36% |